Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma

Published:2011-01-18 Issue:4 Volume:104 Page:719-725
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Greystoke A,O'Connor J P B,Linton K,Taylor M B,Cummings J,Ward T,Maders F,Hughes A,Ranson M,Illidge T M,Radford J,Dive C

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6606082.pdf

Reference22 articles.

1. Adlbrecht C, Hoetzenecker K, Posch M, Steiner S, Kopp C, Hacker S, Auer J, Horvath R, Moser B, Roth G, Wolner E, Lang IM, Ankersmit HJ (2007) Elevated levels of interleukin-1beta-converting enzyme and caspase-cleaved cytokeratin-18 in acute myocardial infarction. Eur J Clin Invest 37: 372–380

2. Barczyk K, Kreuter M, Pryjma J, Booy EP, Maddika S, Ghavami S, Berdel WE, Roth J, Los M (2005) Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy. Int J Cancer 116: 167–173

3. Bertho JM, Demarquay C, Frick J, Joubert C, Arenales S, Jacquet N, Sorokine-Durm I, Chau Q, Lopez M, Aigueperse J, Gorin NC, Gourmelon P (2001) Level of Flt3-ligand in plasma: a possible new bio-indicator for radiation-induced aplasia. Int J Radiat Biol 77: 703–712

4. Buza-Vidas N, Cheng M, Duarte S, Nozad H, Jacobsen SE, Sitnicka E (2007) Crucial role of FLT3 ligand in immune reconstitution after bone marrow transplantation and high-dose chemotherapy. Blood 110: 424–432

5. Cummings J, Ward TH, Greystoke A, Ranson M, Dive C (2008) Biomarker method validation in anticancer drug development. Br J Pharmacol 153 (4): 646–656

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenic Cell Death in Cancer;Interdisciplinary Cancer Research;2023

2. Evaluating the Utility of Proteomics for the Identification of Circulating Pharmacodynamic Biomarkers of IFNβ ‐1a Biologics;Clinical Pharmacology & Therapeutics;2022-11-19

3. Liquid Biopsy in Cancer: Focus on Lymphoproliferative Disorders;Cancers;2022-10-31

4. Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration;Journal of Inflammation Research;2022-10

5. Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer;British Journal of Cancer;2021-12-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3